GSK’s linerixibat helped reduce itch in patients with a rare bile duct disease, meeting its primary endpoint in a late-stage trial.
If approved, linerixibat would …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Bayer Aktiengesellschaft / Key word(s): Change in Forecast Bayer Aktiengesellschaft: Bayer lowers full-year outlook 24-Jul-2023 / 19:32 CET/CEST Disclosure of an inside information acc. to
Presentation A 42-year-old man presented to the doctor with complaints of pain and swelling on his elbow and wrist and decreased range of motion after
Combining machine learning with explainable artificial intelligence (XAI) to predict biological age with personalized explanations.